Patrice Talaga

1.2k citations

26 papers · 924 indexed · h-index 14

Molecular Biology
Cellular and Molecular Neuroscience top 10%
Organic Chemistry top 10%
Psychiatry and Mental health top 5%
Pediatrics, Perinatology and Child Health top 10%

Co-authors: Michel Gillard Henrik Klitgaard Rob Leurs Sylvain Célanire Alain Matagne Maikel Wijtmans Iwan J. P. de Esch Philippe Michel
Topics: Receptor Mechanisms and Signaling (9 papers)Mast cells and histamine (5 papers)Neuropeptides and Animal Physiology (5 papers)
Cited by: Cellular and Molecular Neuroscience Psychiatry and Mental health Sensory Systems
Journals: Journal of Medicinal Chemistry Tetrahedron Biochemical Pharmacology
Partner nations: Belgium France Netherlands

In The Last Decade

Patrice Talaga

26 papers receiving 884 citations

Peers

Countries citing papers authored by Patrice Talaga

Since Specialization

Citations

This map shows the geographic impact of Patrice Talaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Talaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Talaga more than expected).

Fields of papers citing papers by Patrice Talaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrice Talaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Talaga. The network helps show where Patrice Talaga may publish in the future.

Co-authorship network of co-authors of Patrice Talaga

This figure shows the co-authorship network connecting the top 25 collaborators of Patrice Talaga. A scholar is included among the top collaborators of Patrice Talaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice Talaga. Patrice Talaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-κB activation 2010 ·Biochemical Pharmacology ·Jérémie Mortier,Raphaël Frédérick,(unknown),Caroline Remouchamps,Patrice Talaga,Lionel Pochet,Johan Wouters,Jacques Piette,Emmanuel Dejardin,Bernard Masereel	21
2	Histamine H3 receptor ligands with a 3-cyclobutoxy motif: a novel and versatile constraint of the classical 3-propoxy linker 2010 ·MedChemComm ·Maikel Wijtmans,(unknown),Sylvain Célanire,Michel Gillard,Saskia Hulscher,(unknown),(unknown),Remko A. Bakker,(unknown),(unknown),(unknown),(unknown),Henk Timmerman,Rob Leurs,Patrice Talaga,Iwan J. P. de Esch,Laurent Provins	7
3	4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H₃Receptor Agonists 2008 ·Journal of Medicinal Chemistry ·Maikel Wijtmans,Sylvain Célanire,Erwin Snip,Michel Gillard,Edith Gelens,Philippe Collart,Bastiaan J. Venhuis,B. Christophe,Saskia Hulscher,H. van der Goot,Florence Lebon,Henk Timmerman,Remko A. Bakker,Bénédicte Lallemand,Rob Leurs,Patrice Talaga,Iwan J. P. de Esch	20
4	Alkyne–quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Laurent Provins,B. Christophe,Michel Gillard,(unknown),(unknown),Luc Quéré,Patrice Talaga,Michel Guyaux	6
5	SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy 2007 ·Neuropharmacology ·Rafał M. Kamiński,Alain Matagne,Karine Leclercq,Michel Gillard,Philippe Michel,Benoît Kenda,Patrice Talaga,Henrik Klitgaard	137
6	In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: A novel permeability transition pore inhibitor 2005 ·European Journal of Pharmacology ·B. B. Fuks,Patrice Talaga,(unknown),Jean‐Pierre Hénichart,Karine Bertrand,R. Grimée,(unknown)	15
7	Keynote review: Histamine H3 receptor antagonists reach out for the clinic 2005 ·Drug Discovery Today ·Sylvain Célanire,Maikel Wijtmans,Patrice Talaga,Rob Leurs,Iwan J. P. de Esch	165
8	Potent anti-muscarinic activity in a novel series of quinuclidine derivatives 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Patrice Talaga,Luc Quéré,Philippe Collart,B. Christophe,(unknown),(unknown),Dinesh Chimmanamada,Matteo Zanda,Alain Wagner,Charles Mioskowski,R. Massingham,Michel Guyaux	9
9	Dual Acting Antihistaminergic Agents 2004 ·Mini-Reviews in Medicinal Chemistry ·Ralph T. Scannell,Edmond Differding,Patrice Talaga	9
10	Inhibitors of beta-amyloid aggregation: still an issue of structure and function? 2004 ·Drug Discovery Today Therapeutic Strategies ·Patrice Talaga	4
11	Dual NK₁ Antagonists—Serotonin Reuptake Inhibitors as Potential Antidepressants. Part 2. SAR and Activity of Benzyloxyphenethyl Piperazine Derivatives. 2003 ·ChemInform ·Thomas Ryckmans,Olivier Berton,R. Grimée,Thierry Kogej,Yves Lamberty,Patrick Pasau,Patrice Talaga,Christophe Génicot	1
12	Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity 2003 ·Journal of Medicinal Chemistry ·Benoît Kenda,Alain Matagne,Patrice Talaga,Patrick Pasau,Edmond Differding,Bénédicte Lallemand,(unknown),F. Moureau,Henrik Klitgaard,Michel Gillard,B. B. Fuks,Philippe Michel	202
13	A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold 2002 ·Bioorganic & Medicinal Chemistry Letters ·Oumar Diouf,(unknown),(unknown),Michel Gelbcke,Patrice Talaga,B. Christophe,Michel Gillard,R. Massingham,Michel Guyaux	8
14	Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives 2002 ·Bioorganic & Medicinal Chemistry Letters ·Thomas Ryckmans,Olivier Berton,R. Grimée,Thierry Kogej,Yves Lamberty,Patrick Pasau,Patrice Talaga,Christophe Génicot	28
15	First dual NK1 antagonists–serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants 2002 ·Bioorganic & Medicinal Chemistry Letters ·Thomas Ryckmans,(unknown),Olivier Berton,Christophe Génicot,Yves Lamberty,Bénédicte Lallemand,Patrick Pasau,(unknown),Luc Quéré,Patrice Talaga	52
16	Pharmacological evaluation of a diarylmethylene-piperidine derivative: a new potent atypical antipsychotic? 2001 ·Bioorganic & Medicinal Chemistry Letters ·Patrice Talaga,Alain Matagne,Henrik Klitgaard	7
17	Failure of GPI compounds to display neurotrophic activity in vitro and in vivo 2001 ·European Journal of Pharmacology ·Arnaud Bocquet,(unknown),B. B. Fuks,R. Grimée,Patrice Talaga,(unknown),Henrik Klitgaard	22
18	beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality? 2001 ·Mini-Reviews in Medicinal Chemistry ·Patrice Talaga	40
19	Patch testing with the “sesquiterpene lactone mix”: a marker for contact allergy to Compositae and other sesquiterpene‐lactone‐containing plants A multicentre study of the EECDRG 1990 ·Contact Dermatitis ·G. Ducombs,Claude Benezra,Patrice Talaga,Knud Erik Andersen,D. Burrows,José G. Camarasa,A. Dooms‐Goossens,Peter J. Frosch,Jean‐Marie Lachapelle,Torkil Menné,R. J. G. Rycroft,(unknown),S. Shaw,J. D. Wilkinson	63
20	A New Synthesis of γ-Substituted α-Methylene-γ-butyrolactones (2-Methylene-4-alkanolides) using Catalysis by SnCI₂/Amberlyst 15 1990 ·Synthesis ·Patrice Talaga,(unknown),Claude Benezra,Jean‐Luc Stampf	13

About Patrice Talaga

Patrice Talaga is a scholar working on Cellular and Molecular Neuroscience, Sensory Systems and Immunology and Allergy, having authored 26 papers that have together received 924 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Mast cells and histamine (5 papers) and Neuropeptides and Animal Physiology (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (267 citations), Psychiatry and Mental health (211 citations) and Sensory Systems (45 citations). Patrice Talaga has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Michel Gillard, Henrik Klitgaard, Rob Leurs, Sylvain Célanire, Alain Matagne, Maikel Wijtmans, Iwan J. P. de Esch, Philippe Michel, Benoît Kenda and Patrick Pasau. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact